These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2787116)

  • 1. BSF-2/IL-6 does not augment Ig secretion but stimulates proliferation in myeloma cells.
    Tanabe O; Kawano M; Tanaka H; Iwato K; Asaoku H; Ishikawa H; Nobuyoshi M; Hirano T; Kishimoto T; Kuramoto A
    Am J Hematol; 1989 Aug; 31(4):258-62. PubMed ID: 2787116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma.
    Kawano M; Tanaka H; Ishikawa H; Nobuyoshi M; Iwato K; Asaoku H; Tanabe O; Kuramoto A
    Blood; 1989 Jun; 73(8):2145-8. PubMed ID: 2786435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in BSF-2/IL-6 response in advanced cases of multiple myeloma.
    Asaoku H; Kawano M; Iwato K; Tanabe O; Tanaka H; Hirano T; Kishimoto T; Kuramoto A
    Blood; 1988 Aug; 72(2):429-32. PubMed ID: 3261180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of a role of interleukin 11 in the growth of multiple myeloma.
    Paul SR; Barut BA; Bennett F; Cochran MA; Anderson KC
    Leuk Res; 1992; 16(3):247-52. PubMed ID: 1532843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus.
    Tanaka Y; Saito K; Shirakawa F; Ota T; Suzuki H; Eto S; Yamashita U
    J Immunol; 1988 Nov; 141(9):3043-9. PubMed ID: 3262675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G; Gerrard TL; Goldman NG; Pike SE
    J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro Ig-synthesis and proliferative activity in multiple myeloma are stimulated by different growth factors.
    Sonneveld P; Schoester M; de Leeuw K
    Br J Haematol; 1991 Dec; 79(4):589-94. PubMed ID: 1772780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas.
    Kawano M; Hirano T; Matsuda T; Taga T; Horii Y; Iwato K; Asaoku H; Tang B; Tanabe O; Tanaka H
    Nature; 1988 Mar; 332(6159):83-5. PubMed ID: 3258060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.
    Shiao RT; McLeskey SB; Khera SY; Wolfson A; Freter CE
    Leuk Lymphoma; 1996 Apr; 21(3-4):293-303. PubMed ID: 8726410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the B-cell growth-promoting activity of human IL-4, the co-stimulatory assay with anti-immunoglobulin antibodies. Comparison with the B-cell growth-promoting activity of other lymphokines.
    Almerigogna F; Giudizi MG; Biagiotti R; Alessi A; Defrance T; Banchereau J; Ricci M; Romagnani S
    Immunology; 1989 Jun; 67(2):244-50. PubMed ID: 2502497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma.
    Thyphronitis G; Tsokos GC; June CH; Levine AD; Finkelman FD
    Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5580-4. PubMed ID: 2546158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines.
    Armitage RJ; Macduff BM; Spriggs MK; Fanslow WC
    J Immunol; 1993 May; 150(9):3671-80. PubMed ID: 8097223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory influence of IL-4 on human B cell responsiveness.
    Jelinek DF; Lipsky PE
    J Immunol; 1988 Jul; 141(1):164-73. PubMed ID: 2837507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory role of IL-4 on the secretion of Ig by human B cells.
    Splawski JB; Jelinek DF; Lipsky PE
    J Immunol; 1989 Mar; 142(5):1569-75. PubMed ID: 2493049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotypic immunoglobulin secretion by human B cell non-Hodgkin's lymphomas is related to the expression of the interleukin-2 receptor.
    Vyth-Dreese FA; Dellemijn TA; Hekman A; Melief CJ
    Leukemia; 1988 Apr; 2(4):231-5. PubMed ID: 3129622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells.
    Lu ZY; Zhang XG; Rodriguez C; Wijdenes J; Gu ZJ; Morel-Fournier B; Harousseau JL; Bataille R; Rossi JF; Klein B
    Blood; 1995 May; 85(9):2521-7. PubMed ID: 7727780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.
    Shimizu S; Yoshioka R; Hirose Y; Sugai S; Tachibana J; Konda S
    J Exp Med; 1989 Jan; 169(1):339-44. PubMed ID: 2783335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional bioassays for B cell growth factors using polyclonally activated murine spleen B cells.
    Ruuth E; Couillin I; Herbelin A; Praz F
    Lymphokine Res; 1989; 8(2):147-58. PubMed ID: 2471901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM.
    Defrance T; Vanbervliet B; Pène J; Banchereau J
    J Immunol; 1988 Sep; 141(6):2000-5. PubMed ID: 2971718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cytokine activities are related to the suppression of synthesis of normal immunoglobulin in multiple myeloma.
    Kawano M; Iwato K; Asaoku H; Tanabe O; Tanaka H; Ishikawa H; Kuramoto A
    Am J Hematol; 1989 Feb; 30(2):91-6. PubMed ID: 2643860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.